Alibaba Health Information Technology Limited - ADR
ALBBY
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.39B
Close$
$3.86
51.3% downside
Current Fair Value
51.3% downsideOvervalued by 51.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.39 Billion |
|---|---|
| Enterprise Value | $1.57 Billion |
| Dividend Yield | $0.57 (7.45%) |
| Earnings per Share | $2.4 |
| Beta | 1.61 |
| Outstanding Shares | 804,795,000 |
Return
| Return on Equity | 8.42% |
|---|---|
| Return on Assets | 6.51% |
| Return on Invested Capital | 8.84% |
Valuation & Multiples
| P/E Ratio | 21.66 |
|---|---|
| PEG | 22.06 |
| Price to Sales | 0.18 |
| Price to Book Ratio | 0.36 |
| Enterprise Value to Revenue | 0.04 |
| Enterprise Value to EBIT | 0.99 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.58 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Alibaba Health Information Technology Limited
CEO: Shunyan Zhu